Nuzenio

World Cohort

World Cohort entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 2 latest news signals 2 publisher sources 100/100 entity strength

Latest news

B-Cell Depletion Persists Into Third Trimester After Ofatumumab Cessation, Real-World MS Cohort Finds - NeurologyLiveNeurologyLive · Tue, 04 Aug 2026 12:10:27 GMTReal-world outcomes of first-line pembrolizumab plus chemotherapy in metastatic triple-negative breast cancer with central nervous system metastases: a multicenter cohort from Poland, the Czech Republic and Slovakia | Pieniążek | Reports of Practical Oncol - Via Medica JournalsVia Medica Journals · Mon, 03 Aug 2026 14:02:58 GMT

Timeline

Tue, 04 Aug 2026 12:10:27 GMTB-Cell Depletion Persists Into Third Trimester After Ofatumumab Cessation, Real-World MS Cohort Finds - NeurologyLive
Mon, 03 Aug 2026 14:02:58 GMTReal-world outcomes of first-line pembrolizumab plus chemotherapy in metastatic triple-negative breast cancer with central nervous system metastases: a multicenter cohort from Poland, the Czech Republic and Slovakia | Pieniążek | Reports of Practical Oncol - Via Medica Journals

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for World Cohort.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

2 distinct publisher/source names are currently connected to this entity page.